FDA approves drugs despite only ~50% having ≥2 robust trials. Gepirone’s journey highlights lenient regulation with multiple contrasting studies. #DrugEfficacy PMID:42340691, JAMA Psychiatry 2026, @JAMAPsych @Stanford https://doi.org/10.1001/jamapsychiatry.2026.1438 #Medsky #Pharmsky #RNA #ASHG 🧪